MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of SEK 8.85 billion. The enterprise value is 8.92 billion.

Market Cap	8.85B
Enterprise Value	8.92B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

MedCap AB has 14.81 million shares outstanding. The number of shares has increased by 0.55% in one year.

Current Share Class	n/a
Shares Outstanding	14.81M
Shares Change (YoY)	+0.55%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	4.18%
Owned by Institutions (%)	60.21%
Float	11.22M

Valuation Ratios

The trailing PE ratio is 39.09 and the forward PE ratio is 39.08.

PE Ratio	39.09
Forward PE	39.08
PS Ratio	4.92
PB Ratio	7.42
P/TBV Ratio	15.74
P/FCF Ratio	32.81
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.85, with an EV/FCF ratio of 33.05.

EV / Earnings	39.12
EV / Sales	4.95
EV / EBITDA	23.85
EV / EBIT	32.17
EV / FCF	33.05

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.29.

Current Ratio	2.63
Quick Ratio	1.83
Debt / Equity	0.29
Debt / EBITDA	0.93
Debt / FCF	1.29
Interest Coverage	18.74

Financial Efficiency

Return on equity (ROE) is 21.00% and return on invested capital (ROIC) is 12.29%.

Return on Equity (ROE)	21.00%
Return on Assets (ROA)	9.91%
Return on Capital (ROIC)	12.29%
Revenue Per Employee	3.37M
Profits Per Employee	426,966
Employee Count	514
Asset Turnover	1.03
Inventory Turnover	2.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.88% in the last 52 weeks. The beta is 0.72, so MedCap AB's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+75.88%
50-Day Moving Average	553.92
200-Day Moving Average	508.13
Relative Strength Index (RSI)	60.01
Average Volume (20 Days)	30,384

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of SEK 1.80 billion and earned 228.00 million in profits. Earnings per share was 15.30.

Revenue	1.80B
Gross Profit	1.07B
Operating Income	277.30M
Pretax Income	287.40M
Net Income	228.00M
EBITDA	336.60M
EBIT	277.30M
Earnings Per Share (EPS)	15.30

Full Income Statement

Balance Sheet

The company has 287.70 million in cash and 347.50 million in debt, giving a net cash position of -59.80 million or -4.04 per share.

Cash & Cash Equivalents	287.70M
Total Debt	347.50M
Net Cash	-59.80M
Net Cash Per Share	-4.04
Equity (Book Value)	1.20B
Book Value Per Share	80.57
Working Capital	541.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 308.30 million and capital expenditures -38.40 million, giving a free cash flow of 269.90 million.

Operating Cash Flow	308.30M
Capital Expenditures	-38.40M
Free Cash Flow	269.90M
FCF Per Share	18.23

Full Cash Flow Statement

Margins

Gross margin is 59.22%, with operating and profit margins of 15.39% and 12.66%.

Gross Margin	59.22%
Operating Margin	15.39%
Pretax Margin	15.95%
Profit Margin	12.66%
EBITDA Margin	18.68%
EBIT Margin	15.39%
FCF Margin	14.98%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.55%
Shareholder Yield	-0.55%
Earnings Yield	2.56%
FCF Yield	3.05%

Stock Splits

The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a